Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Nemaura Medical Inc. (NMRD)

1.4   -0.03 (-2.1%) 02-03 16:00
Open: 1.42 Pre. Close: 1.43
High: 1.44 Low: 1.33
Volume: 171,907 Market Cap: 34(M)

Technical analysis

as of: 2023-02-03 3:49:32 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 3.04     One year: 4
Support: Support1: 1.26    Support2: 1.05
Resistance: Resistance1: 2.6    Resistance2: 3.43
Pivot: 1.85
Moving Average: MA(5): 1.45     MA(20): 1.84
MA(100): 2.06     MA(250): 2.63
MACD: MACD(12,26): -0.2     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 8     %D(3): 6.5
RSI: RSI(14): 40
52-week: High: 4.57  Low: 1.26
Average Vol(K): 3-Month: 137 (K)  10-Days: 787 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ NMRD ] has closed above bottom band by 24.6%. Bollinger Bands are 135.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 7 days. This is a sign that the current trend might continue.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.53 - 1.54 1.54 - 1.55
Low: 1.38 - 1.39 1.39 - 1.4
Close: 1.41 - 1.43 1.43 - 1.44

Company Description

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

Headline News

Tue, 31 Jan 2023
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD ... - StreetInsider.com

Fri, 27 Jan 2023
U.S. stocks higher at close of trade; Dow Jones Industrial Average ... - Investing.com

Fri, 27 Jan 2023
Health Care Sector Update for 01/27/2023: KERN, NMRD, ARGX ... - Nasdaq

Fri, 27 Jan 2023
Why Applied UV Shares Are Trading Higher By 46%? Here Are ... - Investing.com UK

Fri, 27 Jan 2023
Healthcare Stocks Moving Friday: QNCX, NAMS, HARP, ICVX, NMRD, KERN, CYAD, CYTO - InvestorsObserver

Fri, 27 Jan 2023
Health Care Sector Update for 01/27/2023: NMRD,ARGX,RDHL - Nasdaq

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Neutral
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 0 (M)
Shares Float 24 (M)
% Held by Insiders 9.85e+006 (%)
% Held by Institutions 59.1 (%)
Shares Short 79 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -8.7e+006
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -1
Return on Assets (ttm) 560.9
Return on Equity (ttm) -23.8
Qtrly Rev. Growth 577930
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 1.5961e+007
Qtrly Earnings Growth -0.6
Operating Cash Flow 0 (M)
Levered Free Cash Flow -8 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow -0.04

Stock Dividends

Dividend 0
Forward Dividend 57020
Dividend Yield 0%
Dividend Pay Date 2019-12-04
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.